We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$7.26B
AUM Growth
+$444M
Cap. Flow
-$60.5M
Cap. Flow %
-0.83%
Top 10 Hldgs %
19.44%
Holding
385
New
10
Increased
120
Reduced
188
Closed
6

Top Buys

Rank Stock Value
1
HF
HFF Inc.
HF
+$12.7M
2
NPKI
NPK International
NPKI
+$11.2M
3
CABO icon
Cable One
CABO
+$10.5M
4
MANH icon
Manhattan Associates
MANH
+$7.27M
5
CSGS
CSG Systems International
CSGS
+$6.95M

Top Sells

Rank Stock Value
1
SYNT
Syntel Inc
SYNT
+$18M
2
POLY
Plantronics, Inc.
POLY
+$17.5M
3
BMS
Bemis
BMS
+$16.7M
4
WEX icon
WEX
WEX
+$12.4M
5
XRAY icon
Dentsply Sirona
XRAY
+$8.67M

Sector Composition

Rank Sector Weight
1 Financials 18.63%
2 Healthcare 16.93%
3 Technology 16.2%
4 Industrials 14.29%
5 Consumer Discretionary 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZTS icon
351
Zoetis
ZTS
$30.3B
$348K ﹤0.01%
3,800
– –
MCHP icon
352
Microchip Technology
MCHP
$38.8B
$339K ﹤0.01%
8,580
– –
VSM
353
DELISTED
Versum Materials, Inc.
VSM
$339K ﹤0.01%
9,401
-90
-0.9% -$3.39K
SMFG icon
354
Sumitomo Mitsui Financial
SMFG
$170B
$316K ﹤0.01%
39,335
– –
BCE icon
355
BCE
BCE
$21.4B
$315K ﹤0.01%
7,765
– –
CVS icon
356
CVS Health
CVS
$121B
$304K ﹤0.01%
3,860
-1,550
-29% -$111K
VRTX icon
357
Vertex Pharmaceuticals
VRTX
$130B
$291K ﹤0.01%
1,508
-50
-3% -$8.9K
DUK icon
358
Duke Energy
DUK
$91.8B
$279K ﹤0.01%
3,487
-233
-6% -$18.8K
RSP icon
359
Invesco S&P 500 Equal Weight ETF
RSP
$98.3B
$267K ﹤0.01%
2,500
-375
-13% -$39.6K
CAJ
360
DELISTED
Canon, Inc.
CAJ
$265K ﹤0.01%
8,375
– –
WPP icon
361
WPP
WPP
$5.57B
$252K ﹤0.01%
3,445
– –
SJM icon
362
J.M. Smucker
SJM
$13B
$247K ﹤0.01%
2,412
– –
MS icon
363
Morgan Stanley
MS
$324B
$246K ﹤0.01%
5,283
– –
XYL icon
364
Xylem
XYL
$25.1B
$241K ﹤0.01%
3,016
– –
BBVA icon
365
Banco Bilbao Vizcaya Argentaria
BBVA
$159B
$240K ﹤0.01%
38,075
– –
BNY
366
Bank of New York Mellon
BNY
$105B
$238K ﹤0.01%
4,662
+75
+2% +$3.95K
BP icon
367
BP
BP
$121B
$230K ﹤0.01%
5,227
-235
-4% -$9.83K
IWF icon
368
iShares Russell 1000 Growth ETF
IWF
$123B
$230K ﹤0.01%
5,900
– –
IJR icon
369
iShares Core S&P Small-Cap ETF
IJR
$106B
$226K ﹤0.01%
2,590
– –
SHW icon
370
Sherwin-Williams
SHW
$78.5B
$224K ﹤0.01%
1,476
– –
TRV icon
371
Travelers Companies
TRV
$78.8B
$222K ﹤0.01%
1,710
– –
AZN icon
372
AstraZeneca
AZN
$251B
$214K ﹤0.01%
+2,700
New +$204K
CAT icon
373
Caterpillar
CAT
$360B
$212K ﹤0.01%
+1,392
New +$197K
CRM icon
374
Salesforce
CRM
$210B
$209K ﹤0.01%
+1,313
New +$195K
HIG icon
375
Hartford Financial Services
HIG
$36.8B
$206K ﹤0.01%
4,129
– –
12 13 14
15
16

Similar funds

MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
GLA
Great Lakes Advisors Chicago, Illinois $13.1B AUM 34.09% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Boston Trust Walden's Q3 2018 Portfolio in Review

As of Q3 2018, Boston Trust Walden held 385 positions worth $7.26B, up 6.5% from $6.81B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 4.2%. Boston Trust Walden opened 10 new positions and exited 6, leaving the 385-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q3 2018 buy was HFF Inc.: 301,840 shares worth $12.8M.
  • Boston Trust Walden added most to Manhattan Associates in Q3 2018, an estimated $7.27M increase.
  • Boston Trust Walden's biggest Q3 2018 reduction was Bemis, cutting an estimated $16.7M.
  • Boston Trust Walden fully exited Syntel Inc in Q3 2018, selling an estimated $18M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $7.26B portfolio in Q3 2018.
  • Boston Trust Walden opened 10 new positions and closed 6 in Q3 2018.
  • Boston Trust Walden's portfolio value rose 6.5% quarter-over-quarter to $7.26B.

Based on Boston Trust Walden's 13F filing for Q3 2018, filed 23 Oct 2018.